Drugs / Sinovac
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05343871 Comparator | Jul 2022 → Jul 2023 | COVID-19 | Albert B. Sabin Vaccine Institute | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sinovac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05343871 ↗ |
| Modality | Vaccine | “Sinovac inactivated COVID-19 vaccine:” NCT05343871 ↗ |